These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31670055)

  • 21. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
    Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gut mycobiome: a novel player in chronic liver diseases.
    Jiang L; Stärkel P; Fan JG; Fouts DE; Bacher P; Schnabl B
    J Gastroenterol; 2021 Jan; 56(1):1-11. PubMed ID: 33151407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of gut microbiota in liver disease.
    Albhaisi SAM; Bajaj JS; Sanyal AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
    Solé C; Guilly S; Da Silva K; Llopis M; Le-Chatelier E; Huelin P; Carol M; Moreira R; Fabrellas N; De Prada G; Napoleone L; Graupera I; Pose E; Juanola A; Borruel N; Berland M; Toapanta D; Casellas F; Guarner F; Doré J; Solà E; Ehrlich SD; Ginès P
    Gastroenterology; 2021 Jan; 160(1):206-218.e13. PubMed ID: 32941879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD.
    Dong TS; Katzka W; Lagishetty V; Luu K; Hauer M; Pisegna J; Jacobs JP
    Sci Rep; 2020 Feb; 10(1):2771. PubMed ID: 32066758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
    Brandl K; Schnabl B
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
    Jiang L; Schnabl B
    Physiology (Bethesda); 2020 Jul; 35(4):261-274. PubMed ID: 32490750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases.
    Singh B; Qin N; Reid G
    Inflamm Allergy Drug Targets; 2015; 14(2):84-93. PubMed ID: 26817477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the microbiota in the management of gastrointestinal and liver disease.
    Quigley EM; Monsour HP
    Rev Gastroenterol Peru; 2013; 33(2):139-44. PubMed ID: 23838941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.
    Loomba R; Seguritan V; Li W; Long T; Klitgord N; Bhatt A; Dulai PS; Caussy C; Bettencourt R; Highlander SK; Jones MB; Sirlin CB; Schnabl B; Brinkac L; Schork N; Chen CH; Brenner DA; Biggs W; Yooseph S; Venter JC; Nelson KE
    Cell Metab; 2017 May; 25(5):1054-1062.e5. PubMed ID: 28467925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probiotics and Liver Disease: Where Are We Now and Where Are We Going?
    Elzouki AN
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S188-S190. PubMed ID: 27741172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of the Gut Microbiome in Liver Cirrhosis Treatment.
    Lee NY; Suk KT
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature.
    Giuffrè M; Campigotto M; Campisciano G; Comar M; Crocè LS
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G889-G906. PubMed ID: 32146836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systems biology perspective for studying the gut microbiota in human physiology and liver diseases.
    Altay O; Nielsen J; Uhlen M; Boren J; Mardinoglu A
    EBioMedicine; 2019 Nov; 49():364-373. PubMed ID: 31636011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics in Pediatric Liver Disease.
    Miloh T
    J Clin Gastroenterol; 2015; 49 Suppl 1():S33-6. PubMed ID: 26447962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of γδT cells in liver diseases and its relationship with intestinal microbiota.
    Zhou QH; Wu FT; Pang LT; Zhang TB; Chen Z
    World J Gastroenterol; 2020 May; 26(20):2559-2569. PubMed ID: 32523311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Gut Microbiome Interactions in Service-Related Gastrointestinal and Liver Diseases of Veterans.
    Bajaj JS; Sharma A; Dudeja PK;
    Gastroenterology; 2019 Nov; 157(5):1180-1183.e1. PubMed ID: 31404532
    [No Abstract]   [Full Text] [Related]  

  • 40. The Human Gut Microbiome in Liver Diseases.
    Davis BC; Bajaj JS
    Semin Liver Dis; 2017 May; 37(2):128-140. PubMed ID: 28564721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.